Advanced Cancer Therapeutics Licenses Technology to Develop Human Papillomavirus (HPV) Vaccine

Published: Jul 23, 2008

LOUISVILLE, Ky.--(BUSINESS WIRE)--Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced the signing of two new collaborative agreements that will advance development of the Company’s novel human papillomavirus (HPV) vaccine program.

Back to news